This combination has the potential to be the first treatment option combining an antibody-drug conjugate plus an immunotherapy in this treatment setting
The advanced laboratory spread over 2,200 Square feet has multiple laboratory divisions including Hematology, Biochemistry, Clinical pathology, Serology and Microbiology
CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
The company will submit an action plan on the observations and will engage with US FDA for next steps.
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
This partnership stemmed from a successful customer-supplier relationship spanning several years.
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The investment will enable the company to enter European markets as well as enhance margins in current markets
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
EC grants conditional marketing authorization based on the EFFISAYIL trial
Subscribe To Our Newsletter & Stay Updated
